Filing Details

Accession Number:
0001104659-18-017201
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-03-13 18:15:40
Reporting Period:
2018-03-12
Accepted Time:
2018-03-13 18:15:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
886163 Ligand Pharmaceuticals Inc LGND Pharmaceutical Preparations (2834) 770160744
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1442372 L Stephen Sabba Dorset Management Corp
485 Underhill Blvd Suite 205
Syosset NY 11791
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-03-12 622 $180.73 26,363 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. These securities, as represented in Column 5, include a grant of 666 restricted shares approved by the Board of Directors of the Company at the 2017 Meeting, which shares will vest in full on the earlier of (a) the date of the next annual meeting of the Company stockholders following the grant date or (b) on the first anniversary of the grant date.